Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 16 - Number 12





Identification of Lipid Species Linked to the Progression of Non-alcoholic Fatty Liver Disease

, 16(12): 1293 - 1300

Yuki Kawano, Shin Nishiumi, Masaya Saito, Yoshihiko Yano, Takeshi Azuma and Masaru Yoshida


DOI: 10.2174/1389450116666150408103318



Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease

, 16(12): 1301 - 1314

Wensheng Liu, Susan S Baker, Robert D Baker and Lixin Zhu


DOI: 10.2174/1389450116666150427155342



IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression

, 16(12): 1315 - 1323

Daniel A Giles, Maria E Moreno-Fernandez and Senad Divanovic


DOI: 10.2174/1389450116666150531153627




Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

, 16(12): 1332 - 1346

Michele T. Pritchard and Jennifer M. McCracken


DOI: 10.2174/1389450116666150825111439




ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy

, 16(12): 1356 - 1371

Haigang Cui, Anna J. Zhang, Mingwei Chen and Johnson J. Liu


DOI: 10.2174/1389450116666150330113506







Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 2.19

Related Journals

Related eBooks

eBooks Catalog